BioXcel Therapeutics, Inc. (BTAIQ) stock
BTAIQOTCPharmaceutical PreparationsFiscal year ends December 31
$0.03−0.00 (-13.49%)
Close on Oct 19, 2026Market cap $757.50KP/E –Yield –
BioXcel Therapeutics price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
BioXcel Therapeutics's price to sales ratio was 1.1× on Oct 19, 2026, against 15.6× a year earlier. Over the last 3 years it ranged from 1.1× to 113.2×, with a median of 30.9×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Oct 19, 2026 | 1.1× | −41.5 |
| 2025 | Dec 31, 2025 | 42.5× | +35.6 |
| 2024 | Dec 31, 2024 | 7.0× | −62.6 |
| 2023 | Dec 29, 2023 | 69.5× | – |
See a number that looks wrong?